Read more
Informationen zum Autor Dr Amato teaches at Northeastern University, is a senior lecturer at Boston College and serves on the board of directors for several organizations, including BioSignostix, the Medical Development Group (MDG) and the Association of Graduate Regulatory Educators (AGRE). His research has been extensively published and he has presented on regulatory affairs across the United States, China and India. Klappentext All biomaterials and medical devices are subject to a long list of regulatory practises and policies which must be adhered to in order to receive clearance. This book provides readers with information on the systems in place in the USA and the rest of the world. Chapters focus on a series of procedures and policies including topics such as commercialization, clinical development, general good practise manufacturing and post market surveillance. Zusammenfassung All biomaterials and medical devices are subject to a long list of regulatory practises and policies which must be adhered to in order to receive clearance. This book provides readers with information on the systems in place in the USA and the rest of the world. Inhaltsverzeichnis 1. Biomaterials and their applications in medicine I. Kulinets, Northeastern University, USA 2. Technical considerations for the commercialization of biomaterials N. Scarborough, NLS Consulting, USA and N. Mukherjee, Covidien, USA 3. Regulatory strategies for biomaterials and medical devices in the USA: Classification, design and risk analysis S. F. Amato, Northeastern University, USA 4. Clinical development and endpoint strategies for biomaterials and medical devices S. F. Amato, Northeastern University, USA 5. The clinical evaluation and approval threshold of biomaterials and medical devices K. G. Stevens, DePuy Synthes Spine, USA 6. Supply chain controls for biomaterials and medical devices in the USA S. F. Amato, Northeastern University, USA 7. Global marketing authorisation of biomaterials and medical devices J. J. Tobin, ChemHaz Solutions, Ireland 8. Good manufacturing practice (GMP) for biomaterials and medical devices in the EU and the USA F. Tarabah, Strategiqual, France 9. Post market surveillance approaches for biomaterials and medical devices in the USA K. Desai, Northeastern University, USA 10. Fundamentals of medical device approval in Asia J. L. Wong, ARPA, Hong Kong and P. Teysseyre, Johnson & Johnson Medical Asia Pacific, Singapore ...
List of contents
1. Biomaterials and their applications in medicine
I. Kulinets, Northeastern University, USA
2. Technical considerations for the commercialization of biomaterials
N. Scarborough, NLS Consulting, USA and N. Mukherjee, Covidien, USA
3. Regulatory strategies for biomaterials and medical devices in the USA: Classification, design and risk analysis
S. F. Amato, Northeastern University, USA
4. Clinical development and endpoint strategies for biomaterials and medical devices
S. F. Amato, Northeastern University, USA
5. The clinical evaluation and approval threshold of biomaterials and medical devices
K. G. Stevens, DePuy Synthes Spine, USA
6. Supply chain controls for biomaterials and medical devices in the USA
S. F. Amato, Northeastern University, USA
7. Global marketing authorisation of biomaterials and medical devices
J. J. Tobin, ChemHaz Solutions, Ireland
8. Good manufacturing practice (GMP) for biomaterials and medical devices in the EU and the USA
F. Tarabah, Strategiqual, France
9. Post market surveillance approaches for biomaterials and medical devices in the USA
K. Desai, Northeastern University, USA
10. Fundamentals of medical device approval in Asia
J. L. Wong, ARPA, Hong Kong and P. Teysseyre, Johnson & Johnson Medical Asia Pacific, Singapore
